Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Actin vs Push Health

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.0

Actin

Best for affordable compounded semaglutide with B12 enhancement
★★★3.5

Starting at $133/mo

Compounded SemaglutideB12 Enhanced
Visit Actin
7.1

Push Health

Best for brand-name GLP-1 distribution via large pharmacy network (pending verification)
★★★3.6

Starting at $950/mo

BrandOzempicZepboundMounjaro
Visit Push Health

Side-by-Side Comparison

FeatureActinPush Health
Overall Score7.0/107.1/10
Starting Price$133/mo$950/mo
Editorial Rating3.5 ★ /53.6 ★ /5
Features2 features5 features
States Available00
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Actin

Pros

  • Semaglutide + B12 combination for added energy support
  • Transparent pricing — exact cost shown upfront with no hidden fees
  • Competitive starting price from $133

Cons

  • Semaglutide only — no tirzepatide or liraglutide
  • No visible LegitScript or PCAB accreditation
  • State availability not disclosed
  • Broader platform (hormones, sexual wellness, hair health)

Push Health

Pros

  • Brand-name-only GLP-1 distribution (Ozempic, Zepbound, Mounjaro)
  • 55,000+ pharmacy network per competitor sources
  • LegitScript certified per competitor sources
  • Listed in both competitor directories

Cons

  • Brand-name-only — no compounded option
  • Stub entry — exact pricing, insurance coordination, and clinician workflow need YMYL verification
  • Confidence LOW until verified

Our Verdict

Winner: Push HealthScore: 7.1/10

Push Health edges out Actin with a higher overall score of 7.1/10 and is particularly strong for brand-name GLP-1 distribution via large pharmacy network (pending verification). Actin remains a solid alternative, especially if you're looking for affordable compounded semaglutide with B12 enhancement.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.